Averback Paul 4
4 · NYMOX PHARMACEUTICAL CORP · Filed Nov 6, 2018
Insider Transaction Report
Form 4
Averback Paul
DirectorCEO10% Owner
Transactions
- Sale
Restricted Common
2018-10-26$1.75/sh−100,000$175,000→ 23,331,448 total
4 · NYMOX PHARMACEUTICAL CORP · Filed Nov 6, 2018
Restricted Common